Literature DB >> 14688006

Feasibility of idiotype vaccination in relapsed B-cell malignancies.

Susana Inogés, Mercedes Rodríguez-Calvillo, Ascensión López-Díaz de Cerio, Natalia Zabalegui, Javier Pérez-Calvo, Carlos Panizo, Milagros Hernandez, Braulia Cuesta, Eduardo Rocha, Maurizio Bendandi.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14688006

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  4 in total

Review 1.  Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures.

Authors:  Maurizio Bendandi
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

2.  Idiotype vaccines for lymphoma: Potential factors predicting the induction of immune responses.

Authors:  Susana Inoges; Ascension Lopez-Diaz de Cerio; Helena Villanueva; Fernando Pastor; Elena Soria; Maurizio Bendandi
Journal:  World J Clin Oncol       Date:  2011-06-10

Review 3.  Novel approaches to the immunotherapy of B-cell malignancies: An update.

Authors:  Renier J Brentjens
Journal:  Curr Hematol Malig Rep       Date:  2006-12       Impact factor: 4.213

Review 4.  Hybridoma-Derived Idiotype Vaccine for Lymphoma: Approval Must Wait.

Authors:  Maurizio Bendandi
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.